Best Supermarket Stocks To Buy Right Now

LONDON -- A popular way to dig out reasonably priced stocks with robust growth potential is through the "Growth At A Reasonable Price," or�GARP, strategy.

This theory uses the price-to-earnings to growth (PEG) ratio to show how a share's price weighs up in relation to its near-term growth prospects -- a reading below one is generally considered decent value for money.

Today, I am looking at�Wm. Morrison Supermarkets� (LSE: MRW  ) to see how it measures up.

What are�Morrison's earnings expected to do?

�Metric 2014 2015 EPS Growth -5% 3% P/E Ratio 10.1 9.8 PEG Ratio n/a 2.9

Source: Digital Look.

Morrison is expected to buck four years of consecutive earnings growth with a slight profit dip in the year ending January 2014, although a modest rebound is anticipated by City analysts in the following 12-month period.

5 Best Sliver Stocks To Buy Right Now: Rite Aid Corp (RAD)

Rite Aid Corporation, incorporated in 1968, is a retail drugstore chain in the United States. As of March 3, 2012, the Company operated drugstores in 31 states across the country and in the District of Columbia. As of March 3, 2012, it operated 4,667 stores. In the Company�� stores, it sells prescription drugs and a range of other merchandise, which it calls front end products. During the fiscal year ended March 3, 2012 (fiscal 2012), prescription drug sales accounted for 68.1% of its total sales. The Company carries a range of front end products, which accounted for 31.9% of its total sales in fiscal 2012. Front end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchandise and other everyday and convenience products, as well as photo processing. It offers a variety of products under its private brands, which contributed approximately 17% of its front end sales in the categories where private brand products were offered in fiscal 2012. As of March 3, 2012, the Company had opened over 2,100 GNC stores-within-Rite Aid-stores. During fiscal 2012, the Company sold two owned operating stores to independent third parties.

During fiscal 2012, its stores filled approximately 295 million prescriptions and served an average of 2.1 million customers per day. The overall average size of each store in its chain is approximately 12,600 square feet. As of March 3, 2012, 60% of its stores were freestanding; 51% of its stores included a drive-thru pharmacy; 24% included one-hour photo shops, and 46% included a GNC store-within-Rite Aid-store. The Company�� customers may also order prescription refills over the Internet through www.riteaid.com, or over the phone through its telephonic automated refill systems for pick up at a Rite Aid store. It has a strategic alliance with GNC, a retailer of vitamin and mineral supplements.

Advisors' Opinion:

• [By Dan Caplinger]

  But tech is having no effect on the rest of the market, as earnings season continues to produce some strong results. Drugstore chain Rite Aid (NYSE: RAD  ) has soared nearly 20% on news that the company posted an annual profit last year -- its first gain after four consecutive years of losses. With earnings projections of $0.04 to $0.20 per share for the coming fiscal year, the company is optimistic about its chances to continue rebounding even as competing drugstore chains have seen better growth prospects and have far less debt to worry about. Still, if Rite Aid can keep improving, its beaten-down shares have plenty of room to run higher even after today's jump.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Rite Aid (NYSE: RAD) shot up 12.94 percent to $4.19 after the company posted a profit in its fiscal second quarter.

  Shares of GT Advanced Technologies (NASDAQ: GTAT) got a boost, shooting up 12.52 percent to $8.49. UBS upgraded the stock from Neutral to Buy.

• [By Matthew Smith]

  Speaking of subsectors in the retailing industry we are bullish on, how about the drugstores? They all seem to be running on all cylinders and yesterday Rite-Aid (RAD) had a tremendous day. It was the heaviest traded stock on all of the exchanges and saw its shares rise $0.87 (23.45%) to close at $4.58/share. Rite-Aid is the first among the 'Big Three' to report quarterly results so we find it interesting that they saw an increase in same store sales and saw profits driven by generic drugs. We have been told that this is going to be the bottom line driver for the industry via nearly everyone and that it would impact the top line as generics replaced the more expensive branded drugs. We care about earnings growth more than revenue growth, especially when the stall in revenues is due to switching to higher margin product which is purchased for a lower price. The market gets this and is pushing all of these names higher. In hindsight we wish we had been more bullish of Rite-Aid earlier, but hindsight is always perfect.

• [By Dan Caplinger]

  Rite Aid (NYSE: RAD  ) will release its quarterly report on Thursday, and investors who bucked the popular consensus that the drugstore chain was doomed to failure have reaped the rewards this year, with shares rising nearly sixfold from this time a year ago. But the question remains whether Rite Aid can truly pose a long-term challenge to CVS Caremark (NYSE: CVS  ) and Walgreen (NYSE: WAG  ) , especially with the extensive debt that Rite Aid still has to address.

Best Supermarket Stocks To Buy Right Now: PPJ Enterprise (PPJE)

PPJ Enterprise, Inc. (PPJ), incorporated on May 02, 2000, is a healthcare finance company. The Company is engaged in automated healthcare reimbursement cycle software, online health information digital-systems software and practice information management digital-system software. The Company�� flagship product is its medical billing software system. The Company has developed through its subsidiary Automated Software Corp., a medical billing software system named AutoMed.

The Company�� principal activity is serving as a medical reimbursement consulting firm. The Company�� medical billing system is comprised of both hardware and software. The system uses Optical Character Recognition (OCR)/ Initial Margin Requirement (IMR) scanning technology to allow physicians to bill their medical insurance claims at the point of service without data entry, coding or billing personnel. The Company offers the Automated Biller on a customized basis for medical practices throughout the United States.

Advisors' Opinion:

• [By Peter Graham]

  While small cap green or renewable energy type of stocks have been the flavor of the month for many stock promoters (and sometimes still are), small cap health care stocks like PPJ Enterprise (OTCMKTS: PPJE), Plantation Development Corp (OTCMKTS: BRMA) and MedCAREERS Group Inc (OTCMKTS: MCGI) have also started to get some notice lately ��perhaps because Obamacare has been topping the news lately. However, are these small cap health care stocks a better bet for investors or for their promoters? Here is a quick reality check and a checkup:

Best Supermarket Stocks To Buy Right Now: Enel SpA (ENEL)

Enel SpA is an Italy-based company engaged in the utilities sectors. It operates in seven divisions. The Sales segment focuses on the sale of electricity and gas products and services for end users. The Generation and Energy Management is involved in generation with thermal, natural gas regasification and schedulable hydroelectric power plants. The Infrastructure and Networks distributes electricity and public lighting. The Iberia and Latin America operates in the electricity and gas markets of Spain, Portugal and Latin America. The International segment supports strategies for the European and Russian markets. The Renewable Energy is active in the generation of electricity from renewable resources. The Engineering and Research develops the conventional and nuclear construction of power plants. In November 2013, through Enel Investment Holding BV, it sold a 40% stake in Artic Russia BV, which in turn owns a 49% of the share capital of SeverEnergia, to NK Rosneft' OAO. Advisors' Opinion:

• [By Jonathan Morgan]

  Enel SpA (ENEL) retreated 3.8 percent to 3.22 euros after Deutsche Bank AG said that its estimates for earnings at Italy�� biggest utility show no potential for growth for 2013 or 2014.

Best Supermarket Stocks To Buy Right Now: Network Exploration Ltd (NET)

Network Exploration Ltd. is an exploration and development-stage company. The Company�� principal business activities include the exploration of minerals in its mineral properties. It focuses on base and precious metal properties in North and South America. Its activities include the process of exploring its mineral properties, reviewing and subsequently acquiring mineral properties and conducting exploration programs to determine whether these properties contain ore reserves that are recoverable. The Picha copper-silver project is located within the Tertiary Volcanic Arc of Southern Peru. The Pistala project is located east of the NW-SE trending Incapquio fault system in the Department of Tacna, Southern Peru. The Company is in the business of mineral exploration in Canada, Chile and Peru. Network Exploration Chile Limitada is its wholly owned subsidiary. Advisors' Opinion:

• [By Holly LaFon]

  The MSCI World Index (Net) is a free float-adjusted market capitalization weighted index that is designed to measure the global equity market performance of developed markets. This benchmark calculates reinvested dividends net of withholding taxes using Luxembourg tax rates. This index is unmanaged and investors cannot invest directly in this index.

• [By Patience Investing Inc.]

  Sl. No Portfolio Style Description Annualized Performance (Net) Since Inception or Longest Period Primary Benchmark Relative Performance 1 Emerging Markets Equity Stocks of companies in emerging countries 8.35% 6.29% 2.06% 2 European Equity Stocks of companies in European countries 8.48 6.20 2.28 3 Global Balanced Mix of global stocks and bonds 7.60 6.37 1.23 4 Global Equity Stocks of U.S. & non-U.S. companies 12.40 9.24 3.16 5 Global Mid Cap Equity Stocks of mid-sized U.S. and Non-U.S. companies 3.85 6.14 -2.29 6 Global Small Cap Equity Stocks of smaller U.S. and Non-U.S. companies 6.00 6.26 -0.26 7 International Equity Stocks of non-U.S. companies 9.57 4.56 5.01 8 International Mid Cap Equity Stocks of mid-sized non-U.S. companies 5.61 5.93 -0.32 9 International Small Cap Equity Stocks of smaller non-U.S. companies 7.84 5.87 1.97 10 U.S. Mid Cap Value Equity Stocks of mid-sized U.S. companies 3.40 7.05 -3.65 11 U.S. Small Cap Value Equity Stocks of smaller U.S. companies 3.07 4.84 -1.77 12 U.S. Value Equity Stocks of U.S. companies 6.91 7.81 -0.90 Source: Compiled from http://www.brandes.com/Inv/Pages/Performance.aspx

• [By Jason Rivera]

  Assets:Book Value:Reproduction Value:Current AssetsCash And Cash Equivalents506506Accounts Receivable (Net)3,6193,076Inventories10,0006,000Deferred Income Taxes919460Prepaid Expenses799400Total Current Assets15,8439,986PP&E Net2,4151,449Equity and Other Investments4,5763,432Intangible Assets3,1391,570Deferred Income Taxes991496Total Assets26,96417,387
  Number of shares is 7,383.

Best Supermarket Stocks To Buy Right Now: Radiant Creations Group Inc (RCGP)

Radiant Creations Group, Inc., formerly Nova Mining Corporation, incorporated on December 29, 2005, is an exploration-stage Company. The Company�� principal business is the acquisition and exploration of mineral resources.

As of February 28, 2013, the Company has not determined whether its mineral claims contain reserves that are economically recoverable. During the fiscal 2013, the Company had not generated any revenue.

Advisors' Opinion:

• [By Peter Graham]

  What�� the Catch With Axxess Pharma Inc? According to various disclosures, transactions of $2.5k, $3k, $4k, $14k, $25k, $50k and $85k have or will occur to mention Axxess Pharma Inc in various investment newsletters plus the company has been busy announcing new deals. Last Wednesday, Axxess Pharma Inc announced it had signed term sheet from TCA Global Credit Masters Fund to secure a $4 million revolving line of credit which was expected to close within 14 days pending final due diligence. The press release stated the revolving line of credit would enable Axxess Pharma to ��enerate significant revenue in the near-term with high gross profit margins��plus the deal was expected to be the beginning of a long-term long-term partnership between the two companies. Last Monday, Axxess Pharma Inc also announced an exclusive agreement providing them the world-wide exclusive rights to develop, market and sell a line of pain relief and muscle recovery products, as well as develop and market a vitamins and minerals line under the TapouT brand name; while back in September, the company announced an agreement for the acquisition of the assets of Revive Bioscience Inc. - a leading Canadian OTC healthcare company. However, a quick look at both Google Finance and Yahoo! Finance reveals no financials for Axxess Pharma Inc ��meaning its investor beware.

  Radiant Creations Group Inc (OTCBB: RCGP) Is Launching Its Direct to Consumer Sales Model

  Small cap Radiant Creations Group Inc says it has achieved exciting breakthroughs creating remarkable products in skin protection and hydration, anti-aging, liver health and weight balance by combining DNA technologies developed in the Western World and naturally acting traditional Chinese medicine ingredients believed to be never before used in western culture by any bioscience company. On Friday, Radiant Creations Group Inc fell 9.1% to $0.20 for a market cap of $6 million plus RCGP is up 53.85 ov

Best Supermarket Stocks To Buy Right Now: China Biologic Products Inc.(CBPO)

China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People?s Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers Human Hepatitis B Immunoglobulin for the prevention of measles and contagious hepatitis; Human Immunoglobulin and Human Immunoglobulin for Intravenous Injection products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides Injection that is used in the treatment of various original and sec ondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides Human Rabies Immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; Human Tetanus Immunoglobulin for the prevention and therapy of tetanus; and Placenta Polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company?s products under development comprise Human Prothrombin Complex Concentrate; Human Coagulation Factor VIII; Human Hepatitis B Immunoglobulin (PH4) for Intravenous Injection; Human Fibrinogen; Varicella Hyperimmune Globulins; and Human Immunoglobulin for Intravenous Injection. The company is based in Beijing, the People's Republic of China.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.